French Medical Tech Firm Safe SA Expands US Presence with Strategic Partnership

Safe SA, a French medical technology group, signs a strategic partnership with a California-based hospital group, expanding its presence in the US spine market. The partnership ensures a minimum turnover for the company in the future.

author-image
Nitish Verma
New Update
French Medical Tech Firm Safe SA Expands US Presence with Strategic Partnership

French Medical Tech Firm Safe SA Expands US Presence with Strategic Partnership

Safe SA, a French medical technology group, announced safe, signs, strategic, partnership with a California-based hospital group on May 13, 2024, marking a significant expansion of its presence in the US spine market. The partnership ensures a minimum turnover for the company in the future.

Why this matters: This partnership highlights the growing importance of international collaboration in the medical technology industry, as companies seek to expand their reach and improve healthcare outcomes globally. The success of this partnership could pave the way for further collaborations, driving innovation and improving access to medical technologies worldwide.

The partnership involves a referencing contract with Safe, signs, strategic, partnership, States, hospi group of American hospitals based in California, comprising 3,000 affiliated doctors, 30 outpatient centers and clinics, and 100 doctors' offices across the state. This agreement marks an acceleration of Safe SA's turnaround, recognizing the company's solutions in the American healthcare system.

Nicolas Papillon, Deputy Managing Director, stated: "This signature is a further acceleration of the turnaround of SAFE. This is recognition of our solutions by a player well established in the American healthcare system. We are very happy with this agreement, first success of the new management team, which reinforces our mission to revive SAFE." The partnership aligns with Safe SA's development dynamic, demonstrating its ability to market ready-to-use technologies that meet the highest market standards internationally.

Safe Group, the parent company of Safe SA, is a French medical technology group consisting of Safe Orthopaedics and Safe Medical (formerly LCI Medical). The group employs approximately 100 people. Safe Orthopaedics develops and manufactures ready-to-use technologies for spine pathologies, including SteriSpineTM kits, which are CE marked and FDA approved. Safe Medical produces implantable medical devices and ready-to-use instruments, offering industrial services such as industrialization, machining, finishing, and sterile packaging.

The strategic partnership with the California-based hospital group solidifies Safe SA's presence in the US spine market and ensures a minimum turnover for the company in the future. Safe Group's 2023 annual results and financial report are scheduled for release in June 2024.

Key Takeaways

  • Safe SA signs strategic partnership with California-based hospital group.
  • Partnership ensures minimum turnover for Safe SA in the future.
  • Deal marks expansion of Safe SA's presence in US spine market.
  • Partnership involves referencing contract with 3,000 affiliated doctors.
  • Safe Group's 2023 annual results to be released in June 2024.